| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 11/25/2010 | US20100297184 Vaccines |
| 11/25/2010 | US20100297183 Immunogenic streptococcus proteins |
| 11/25/2010 | US20100297180 Botulinum neurotoxin vaccine |
| 11/25/2010 | US20100297179 Immunology Treatment for Biofilms |
| 11/25/2010 | US20100297177 Mutated parvovirus structural proteins as vaccines |
| 11/25/2010 | US20100297176 Polyinosinic Acid - Polycytidylic Acid - Based Adjuvant |
| 11/25/2010 | US20100297172 Replication-defective arenavirus vectors |
| 11/25/2010 | US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications |
| 11/25/2010 | US20100297167 Method for the Production of Recombinant Virus, DNA Constructs, Recombinant Virus and Vaccine Compositions |
| 11/25/2010 | US20100297165 Immunostimulatory combinations of tlr ligands and methods of use |
| 11/25/2010 | US20100297164 Chlamydial Antigens |
| 11/25/2010 | US20100297163 Recombinant malaria vaccine |
| 11/25/2010 | US20100297159 Thomsen-friedenreich disaccharide modified immunogen (tfd), preparation procedure, compositions comprising it, uses, and treatment methods |
| 11/25/2010 | US20100297158 Anticancer vaccine and diagnostic methods and reagents |
| 11/25/2010 | US20100297156 Analogues of phosphatidylinositol mannosides |
| 11/25/2010 | US20100297155 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof |
| 11/25/2010 | US20100297154 CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen |
| 11/25/2010 | US20100297151 Antibodies against human il-21 receptor and uses therefor |
| 11/25/2010 | US20100297150 Disease treatment via antimicrobial peptide inhibitors |
| 11/25/2010 | US20100297146 Immune system programming through b7-dc |
| 11/25/2010 | US20100297139 Methods and compositions for the treatment of proteinuric diseases |
| 11/25/2010 | US20100297137 Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy |
| 11/25/2010 | US20100297135 Epitope for neutralizing antibodies |
| 11/25/2010 | US20100297131 Binding domain of plasmodium reticulocyte binding proteins |
| 11/25/2010 | US20100297127 Use of il-27 antagonists to treat lupus |
| 11/25/2010 | US20100297123 Combination therapy to inhibit t cell effector function |
| 11/25/2010 | US20100297122 Formulations for taci-immunoglobulin fusion proteins |
| 11/25/2010 | US20100297114 Antigen presenting cell targeted vaccines |
| 11/25/2010 | US20100297094 Therapy or prevention of diseases with cells or cell supernatant |
| 11/25/2010 | US20100297071 Immune response inducer |
| 11/25/2010 | US20100297066 Biodegradable peptide releasing polymers |
| 11/25/2010 | US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 11/25/2010 | US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
| 11/25/2010 | US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 11/25/2010 | CA2764931A1 Engineered type iv pilin of clostridium difficile |
| 11/25/2010 | CA2761954A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
| 11/25/2010 | CA2753560A1 Inhibitors of phosphatidylinositol 3-kinase |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253323A1 Anti-allergic agent |
| 11/24/2010 | EP2253319A1 Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2253313A1 Tranilast as modulator of T cell functioning for use in the treatment of autoimmune diseases |
| 11/24/2010 | EP2252617A1 6-aryl-imidaz0[l, 2-a]pyrazine derivatives, method of making, and method of use thereof |
| 11/24/2010 | EP2252612A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 11/24/2010 | EP2252609A1 Pyridin-2-yl derivatives as immunomodulating agents |
| 11/24/2010 | EP2252601A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 11/24/2010 | EP2252326A1 Vaccine compositions |
| 11/24/2010 | EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 11/24/2010 | EP2252319A2 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
| 11/24/2010 | EP1603917B1 Immunomodulating heterocyclic compounds |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1501829B1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | CN1997367B Composition for the prevention and treatment of allergic inflammatory disease |
| 11/24/2010 | CN1927879B Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 11/24/2010 | CN101896482A Novel thiophene derivatives as S1P1/EDG1 agonist |
| 11/24/2010 | CN101896198A Ligands of HVEM for treating hematologic malignancies and autoimmune diseases |
| 11/24/2010 | CN101896191A System for delivery into a XCR1 positive cell and uses thereof |
| 11/24/2010 | CN101896188A Use of microvesicles (MVS) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101891837A Carboxymethylation bifidobacterium exopolysaccharide, preparation method thereof and application thereof |
| 11/24/2010 | CN101891836A Method for extracting white mushroom lentinan assisted with ultrasonic wave |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891814A Anti-osteopontin OPN monoclonal antibody and application thereof |
| 11/24/2010 | CN101891738A Dasatinib polymorph and preparation method and medical composite thereof |
| 11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890154A Application of cobra short-chain neurotoxin in preparation of immunosuppressive drugs |
| 11/24/2010 | CN101890130A Health wine raw materials and health wine |
| 11/24/2010 | CN101890107A Medicament used for regulating immunologic balance and improving disease-resistant capacity of animals |
| 11/24/2010 | CN101890097A Chinese medicinal composite biopolypeptide composition |
| 11/24/2010 | CN101890084A Semen nigellae total glycoside extract and preparation method and application thereof |
| 11/24/2010 | CN101890056A Medicinal composition for enhancing immunologic function |
| 11/24/2010 | CN101890045A External medicament for treating infantile eczema |
| 11/24/2010 | CN101890012A Paracetamol,loratadine and pseudoephedrine sulfate sustained release tablet and preparation method thereof |
| 11/24/2010 | CN101889976A Acyclovir injection and preparation method thereof |
| 11/24/2010 | CN101889964A Desensitizing toothpaste |
| 11/24/2010 | CN101889953A Device and method for manufacturing drug smoke liquid and drug smoke |
| 11/24/2010 | CN101357175B Traditional Chinese medicine composition of foot soaking and massage |
| 11/24/2010 | CN101204580B Application of Vibrio alginolyticus-OmpA as animal immunity regulator |
| 11/24/2010 | CN101175722B Azetidine derivatives as ccr-3 receptor antagonists |
| 11/24/2010 | CN101167730B Compound betamethasone suspension injection |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838635 CD16A binding proteins and use for the treatment of immune disorders |
| 11/23/2010 | US7838557 treating an allergic reaction by topically administering a therapeutically effective amount of an X-ray contrast medium comprising a triiodinated benzene moiety that is completely or partially substituted, and where contrast medium is a non-ionic or ionic monomer, a non-ionic or ionic dimer |
| 11/23/2010 | US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| 11/23/2010 | US7838489 tumor necrosis factor (TNF) receptors, immunoglobuin fusion proteins; anti-tumor necrosis factor antibodies; Crohn's disease, and acute and chronic immune diseases associated with transplantation |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838050 Cytokine modulators and related method of use |
| 11/23/2010 | US7838041 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy |
| 11/23/2010 | US7838014 isolated Neisserial bleb preparation from an engineered Neisserial strain with an L3 LOS immunotype wherein the IgtB gene has been inactivated resulting in an intermediate LOS structure in which the terminal galactose residue and sialic acid are absent |
| 11/23/2010 | US7838001 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
| 11/23/2010 | US7836883 Methods for treating rhinitis and conjunctivitis |
| 11/23/2010 | CA2459380C Reverse hydroxamic acid derivatives |
| 11/23/2010 | CA2444529C Micellar drug delivery systems for hydrophobic drugs |
| 11/23/2010 | CA2342200C Use of certain drugs for treating nerve root injury |